The market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why ICU Stock dropped -6.85% Today — RQD Quant Desk Flash
SeaStar Medical Holding Corporation (ICU) carries a Roarable Rating of E (Strong Sell) with 33/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9
FRED Regime × Technicals: 6% of 52W Range • RSI-14 at 35.4 (NEUTRAL RANGE)
Capital intensity & 0% operating margin leave 16 pts on the table
⚔️ Adversarial Opposing Case: What Could Spark a ICU Turnaround Squeeze
While ICU currently carries a cautious 33/100 (E) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Health Care with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.20) and Max Pain ($2.43) forces dealer call-delta covering toward $6.30.
Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.72% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why ICU Stock dropped -6.85% Today — RQD Quant Desk Flash
SeaStar Medical Holding Corporation (ICU) dropped -6.85% to $2.31, trading at 6% of its 52-week range ($2.07 – $6). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 6% of its 52-week range ($2.07 – $6) with RSI-14 at 35.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $2.31 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 95.7% gross margin and $0 annual free cash flow.
Haley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
Israeli strikes kill eight people in Gaza - medics say Reuters
Russia's FSB says minor detained over park attack threat after US tip-off Reuters
Iran, Qatari mediators hold third day of talks to end US-Iran war Reuters
Qatar surges, bucking Gulf market slide on Iran war concerns Reuters
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
German ministers pledge tough action after rioters damage stores in Frankfurt Reuters
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ICU)
- ✓Walkthrough of ICU's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
ICU Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ICU today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ICU. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ICU)
1. Head-to-Head Health Care Peer Comparison (ICU vs. SINT, FEMY, GUTS, CNSY)
Industry: Medical/Dental Instruments (120 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, SeaStar Medical Holding Corporation (ICU) ranks #880 by composite RQD confidence (33/100, grade E) and #878 by equity capitalization ($12.2M). Within this direct 5-issuer industry benchmark cohort, ICU leads on earnings valuation at N/A trailing P/E, while ICU leads on capital efficiency and profitability with -35.0% ROIC and 95.7% gross margin. GUTS currently holds the highest overall quantitative score in the immediate peer group at 52/100 (D+) compared with ICU at 33/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ICU
ACTIVE
SeaStar Medical Holding Corporation | E | 33/100 | — | 95.7% | -35.0% | -6.85% | $12.2M | Benchmark Subject |
| SINT SiNtx Technologies Inc. | D- | 37/100 | — | 45.3% | -35.0% | -1.15% | $13.0M | /sint-vs-icu → |
| FEMY Femasys Inc. | D- | 35/100 | — | 62.0% | -35.0% | -3.90% | $11.3M | /femy-vs-icu → |
| GUTS Fractyl Health Inc. | D+ | 52/100 | — | — | -35.0% | +11.40% | $13.2M | /guts-vs-icu → |
| CNSY Cerenome Inc. | D- | 36/100 | — | — | -35.0% | 0.00% | $13.2M | /cnsy-vs-icu → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001831868In its most recent audited fiscal period (FY2025, filed 2025-12-31), SeaStar Medical Holding Corporation (ICU) reported GAAP revenue of $1.2M (+814.1% vs. FY2024 revenue of $135.0K ) , GAAP net income of -$12.2M, operating cash flow of -$13.6M, and free cash flow of -$13.6M (+15.0% YoY). On the balance sheet, ICU closed FY2025 with $14.2M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $1.2M | -$12.2M | -$13.6M | -$13.6M | $14.2M | — |
| FY2024 (FY) | 2024-12-31 | $135.0K | -$24.8M | -$16.0M | -$16.0M | $4.7M | — |
| FY2023 (FY) | 2023-12-31 | $0 | -$26.2M | -$10.3M | -$10.3M | — | — |
3. ICU Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ICU stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, SeaStar Medical Holding Corporation (NASDAQ: ICU) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 33/100 at a spot price of $2.31 (-6.85% 1D, market cap $12.2M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, ICU ranks #880 in composite RQD confidence.
How does ICU compare to SINT and FEMY in the Health Care sector?
Within the Health Care sector (Medical/Dental Instruments), ICU carries a Roarable E (33/100 RQD), trailing P/E of N/A, gross margin of 95.7%, and ROIC of -35.0%. By comparison, SINT (SiNtx Technologies Inc.) holds a D- grade (37/100 RQD, P/E N/A, ROIC -35.0%, cap $13.0M) and FEMY (Femasys Inc.) posts a D- grade (35/100 RQD, P/E N/A, ROIC -35.0%, cap $11.3M). Among the 5-stock peer group, ICU leads on earnings multiple (N/A) while ICU leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ICU?
Per ICU's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001831868), SeaStar Medical Holding Corporation generated $1.2M in revenue (+814.1% YoY), -$12.2M in net income, and -$13.6M in free cash flow against $14.2M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ICU trading relative to its 50-day, 200-day, and 52-week technical levels?
ICU last traded at $2.31 (-6.85% on volume of 124,439 shares), positioning the stock -27.81% below its 50-day simple moving average ($3.20) and -30.63% below its 200-day simple moving average ($3.33). Across its 52-week range of $2.07 to $6.00, ICU sits at the 6.1% percentile with a 14-day RSI of 35.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.02 to $2.60).
ICU Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ICU stock moving today?
Why ICU Stock dropped -6.85% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.